Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury

Intensive Care Medicine

Volumn 39, Issue 3, 2013, Pages 497-510

  Matějková, Šárka ^a   Scheuerle, Angelika ^a   Wagner, Florian ^a   McCook, Oscar ^a   Matallo, José ^a   Gröger, Michael ^a   Seifritz, Andrea ^a   Stahl, Bettina ^a   Vcelar, Brigitta ^b   Calzia, Enrico ^a   Georgieff, Michael ^a   Möller, Peter ^a   Schelzig, Hubert ^c   Radermacher, Peter ^a   Simon, Florian ^a,c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Polymun Scientific GmbH   (Austria)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

8 isoprostanes; Apoptosis; Creatinine clearance; Cytokines; Endothelial NO synthase; EPO receptor; Fractional Na+ sodium excretion; Glomerular filtration; HE staining; Neutrophil gelatinase associated lipocalin; Nitric oxide; PAS staining; Tubular reabsorption

Indexed keywords

8 ISOPROSTANE; ADENOSINE TRIPHOSPHATE; CARBAMYLATED ERYTHROPOIETIN FC FUSION PROTEIN; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN RECEPTOR; ESMOLOL; GLYCERYL TRINITRATE; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITRATE; NORADRENALIN; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; HEART PRELOAD; KIDNEY ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR WEIGHT; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; SODIUM EXCRETION; SWINE;

ANIMALS; ERYTHROPOIETIN; IMMUNOGLOBULIN G; KIDNEY; MALE; RECOMBINANT PROTEINS; REPERFUSION INJURY; SWINE;

EID: 84884213624     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2766-y     Document Type: Article

References (61)

1. Gelman S (1995) The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 82:1026-1057
2. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM (2004) Erythropoietin protects the kidney against injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15:2115-2124
3. Patel NSA, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, Thiemermann C (2004) Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 66:983-989
4. Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW (2004) Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19:348-355
5. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C (2005) Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 75:1100-1105
6. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D (2006) Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 21:330-336
7. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobé GC (2006) Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 69:1806-1813
8. Nijboer WN, Ottens PJ, van Dijk A, van Goor H, Ploeg RJ, Leuvenink HGD (2010) Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function. Crit Care Med 38:1155-1161
9. Forman CJ, Johnson DW, Nicol DL (2007) Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU Int 99:162-165
10. Simon F, Scheuerle A, Calzia E, Bassi G, Öter S, Nguyen Duy C, Kick J, Brückner UB, Radermacher P, Schelzig H (2008) Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury. Crit Care Med 36:2143-2150
11. Maio R, Sepodes B, Patel NS, Thiemermann C, Mota-Filipe H, Costa P (2011) Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death. Shock 35:126-133
12. Sølling C, Christensen AT, Krag S, Frøklær J, Wogensen L, Krog J, Tønnesen EK (2011) Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury. Acta Anaesthesiol Scand 55:185-195
13. Ishii Y, Sawada T, Murakami T, Sakuraoka Y, Shiraki T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S (2011) Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrol Dial Transplant 26:1157-1162
14. Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY (2009) Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting. Am J Nephrol 30:253-260
15. Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchinson R, Mehrtens JE, Robinson JM, Schollum JBW, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM (2010) Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 77:1020-1030
16. Brines M, Grasso G, Fiordaliso F, Sfaceteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroceptor. Proc Natl Acad Sci U S A 101:14907-14912
17. Coleman TR, Westenfelder C, Tögel FE, Yang Y, Hu Z, Swenson LA, Leuvenink HGD, Ploeg RJ, d'Uscio LV, Katusic ZS, Ghezzi P, Zanetti A, Kaushansky K, Fox NE, Cerami A, Brines M (2006) Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci U S A 103:5965-5970
18. Brines M, Cerami A (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Int Med 264:405-432
19. Leist M, Ghezzi P, Grasso G, Bianchi R, Viia P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242
20. Schriebl K, Trummer E, Lattenmayer C, Weik R, Kunert R, Müller D, Katiger H, Vorauer-Uhl K (2006) Biochemical characterization of rhEPO-Fc fusion protein expressed in CHO cells. Protein Expr Purif 49:265-275
21. Simon F, Scheuerle A, Gröger M, Vcelar B, Möller P, Georgieff M, Calzia E, Radermacher P, Schelzig H (2011) Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury. Intensive Care Med 35:1525-1533
22. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ (1993) Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 17:357-370
23. Black SA, Brooks MJ, Naidoo MN, Wolfe JH; Joint Vascular Research Group (2006) Assessing the impact of renal impairment on outcome after arterial intervention: a prospective review of 1,559 patients. Eur J Vasc Endovasc Surg 32:300-304
24. Safi HJ, Harlin SA, Miller CC, Iliopoulos DC, Joshi A, Mohasci TG, Zippel R, Letsou GV (1996) Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery. J Vasc Surg 24:338-345
25. Thim T, Hagensen MK, Drouet L, Bal Dit Sollier C, Bonneau M, Granada JF, Nielsen LB, Paaske WP, Bøtker HE, Falk E (2010) Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies. EuroIntervention 6:261-268
26. Hasler-Rapacz J, Ellegren H, Fridolfsson AK, Kirkpatrick B, Kirk S, Andersson L, Rapacz J (1998) Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet 76:379-386
27. Simon F, Scheuerle A, Gröger M, Stahl B, Wachter U, Vogt J, Speit G, Hauser B, Möller P, Calzia E, Szabó C, Schelzig H, Georgieff M, Radermacher P, Wagner F (2011) Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury. Shock 35:156-163
28. Jochmanns I, Lerut E, van Pelt J, Monbaliu D, Pirenne J (2011) Circulating AST, H-FABP, and NGAL are early and accurate biomarkers of graft injury and dysfunction in a preclinical model of kidney transplantation. Ann Surg 254:784-792
29. Cruz DN, Ricci Z, Ronco C (2009) Clinical review: RIFLE and AKIN - time for reappraisal. Crit Care 13:211
30. Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, Doni M, Mengozzi M, Tonelli R, Ghezzi P, Coleman T, Brines M, Cerami A, Latini R (2005) A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci USA 102:2046-2051
31. Xu X, Cao Z, Cao B, Li J, Guo L, Que L, Ha T, Chen Q, Li C, Li X (2009) carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Surgery 146:506-514
32. Xu K, George I, Klotz S, Hay I, Xydas S, Zhang G, Cerami A, Wang J (2010) Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure. J Cardiovasc Pharmacol 56:506-512
33. Grams ME, Rabb H (2012) The distant organ effects of acute kidney injury. Kidney Int 81:942-948
34. Kristensen J, Soegaard H, Maeng M, Rehling M, Nielsen TT (2006) Acute haemodynamic effects of erythropoietin alone and in combination with dopamine in a porcine model. Clin Physiol Funct Imaging 26:283-287
35. Jie KE, Verhaar MC, Cramer MJM, van der Putten K, Gaillard CAJM, Doevendans PA, Koomans HA, Joles JA, Braam B (2006) Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol 291:F932-F944
36. van der Putten K, Braam B, Jie KE, Gaillard CAJM (2008) Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol 4:47-57
37. Stenvinkel P, Bárány P (2002) Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 17(Suppl 5):32-37
38. Kawata T, Hashimotot S, Koike T (1998) Effects of chronic nitric oxide synthase inhibition on renal function and histology in polycythemic rats. Kidney Blood Press Res 21:22-28
39. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS (2007) Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 49:1142-1148
40. Rodríguez JA, Grau A, Eguinoa E, Nespereira B, Pérez-Ilzarbe M, Arias R, Belzunce MS, Páramo JA, Martínez-Caro D (2002) Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesteremia in vivo and in vitro. Atherosclerosis 165:33-40
41. Chade AR, Rodriguez-Porcél M, Grande JP, Krier JD, Lerman A, Carlos Romero J, Napoli C, Lerman LO (2002) Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106:1165-1171
42. Chade AR, Rodriguez-Porcél M, Herrmann J, Zhu X, Grande JP, Napoli C, Lerman A, Lerman LO (2004) Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 15:958-966
43. Kawashima S, Yokoyama M (2004) Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24:998-1005
44. Simmons MN, Schreiber MJ, Gill IS (2008) Surgical renal ischemia: a contemporary overview. J Urol 180:19-30
45. Laven BA, Orvieto MA, Chuang MS, Ritch CR, Murray P, Harland RC, Inman SR, Brendler CB, Shalhav AL (2004) Renal tolerance to prolonged warm ischemia time in a laparoscopic versus open surgery porcine model. J Urol 172:2471-2474
46. Baldwin DD, Maynes LN, Berger KA, Desai PJ, Zuppan CW, Zimmerman GJ, Winkielman AM, Sterling TH, Tsai CK, Ruckle HC (2004) Laparoscopic warm renal ischemia in the solitary porcine kidney model. Urology 64:592-597
47. Orvieto MA, Tolhurst SR, Chuang MS, Lyon MB, Ritch CR, Rapp DE, Shalhav AL (2005) Defining the maximal renal tolerance to warm ischemia in porcine laparoscopic and open surgery model. Urology 66:1111-1115
48. Humphreys MR, Castle EP, Lohse CM, Sebo TJ, Leslie KO, Andrews PE (2009) Renal ischemia time in laparoscopic surgery: an experimental study in a porcine model. Int J Urol 16:105-109
49. Sabbagh R, Chawla A, Tisdale B, Kwan K, Chatterjee S, Kwiecien JM, Kapoor A (2011) Renal histopathology features according to various warm ischemia times in porcine laparoscopic and open surgery model. Can Urol Assoc J 5:40-43
50. Orvieto MA, Zorn KC, Mendiola F, Lyon MB, Mikhail AA, Gofrit ON, Shalhav AL (2007) Recovery of renal function after complete renal hilar versus artery alone clamping during open and laparoscopic surgery. J Urol 177:2371-2374
51. Novick AC (1983) Renal hypothermia: in vivo and ex vivo. Urol Clin N Am 10:637-644
52. Moyer JH, Heider C, Morris GC, Handley C (1957) Hypothermia: III. The effect of hypothermia on renal damage resulting from ischemia. Ann Surg 146:152-166
53. Ward JP (1975) Determination of the optimum temperature for regional renal hypothermia during temporary renal ischaemia. Br J Urol 47:17-24
54. Brasile L, Green E, Haisch C (1997) Ex vivo resuscitation of kidney after postmortem warm ischemia. ASAIO J 43:M427-M430
55. de Albuquerque Dos Santos Abreu A, Kawano PR, Yamamoto H, Damião R, Fugita OEH (2011) Comparative study between trimetazidine and ice slush hypothermia in protection against renal ischemia/reperfusion injury in a porcine model. Int Braz J Urol 37:649-656
56. Zager RA, Altschuld R (1986) Body temperature: an important determinant of the severity of ischemic renal injury. Am J Physiol Renal Fluid Electrolyte Physiol 251:F87-F93
57. Zager RA, Gmur DJ, Bredl CR, Eng MJ (1989) Degree and time sequence of hypothermic protection against experimental ischemic acute renal failure. Cric Res 65:1263-1269
58. Pelkey TJ, Frank RS, Stanley JJ, Frank TS, Zelenock GB, D'Alecy LG (1992) Minimal physiologic temperature variations during renal ischemia alter functional and morphologic outcome. J Vasc Surg 15:619-625
59. Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor JL (2007) The effect of body temperature in a rat model of renal ischemia-reperfusion injury. Transplant Proc 39:2983-2985
60. Gröger M, Scheuerle A, wagner F, Simon F, Matallo J, McCook O, Seifritz A, Stahl B, Wachter U, Vogt JA, Asfar P, Matejovic M, Möller P, Lampl L, Bracht H, Calzia E, Georgieff M, Radermacher P, Stahl W (2013) Effects of prophylactic hypothermia during resuscitated porcine hemorrhagic shock. Crit Care Med (in press)
61. Miller Q, Peyton BD, Cohn EJ, Holmes GF, Harlin SA, Bird ET, Harre JG, Miller ML, Riley KD, Hogan MB, Taylor A (2003) The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. Ann Vasc Surg 17:656-662